Bill Snow was Director of the Global HIV Vaccine Enterprise Secretariat, which represents the alliance of organizations conceived in 2003 to accelerate the search for an HIV vaccine, through mutual coordination, collaboration, knowledge sharing and increasing and optimizing resources to the field. Starting at the Enterprise Secretariat in 2012, Bill restructured Enterprise activities by reshaping the Strategic Convening function: with the Timely Topics in HIV Vaccines program, strategy roundtables and Enterprise Explorations with four focus areas. The Secretariat holds regular meetings of funders and clinical collaborators and work with industry advisors. The Secretariat is also hosting the new HIV Research for Prevention (R4P) Conference, the world’s first and only scientific meeting dedicated exclusively to biomedical HIV prevention research. An advocate for HIV vaccines since 1990, he was instrumental in establishing national, local and global community advisory boards at the NIH clinical trial networks and continues to serves on many scientific leadership and review groups. Bill was a founder of AVAC and has written about the many challenges of developing AIDS vaccines, including major portions of the first several AVAC reports and the first edition of AVAC’s widely used HIV Vaccines Handbook.
Bill Snow
Senior Advisor